Marc Lobbes
Marc Lobbes
Assistant professor Radiology
Потвърден имейл адрес: mumc.nl
Supplemental MRI screening for women with extremely dense breast tissue
MF Bakker, SV de Lange, RM Pijnappel, RM Mann, PHM Peeters, ...
New England Journal of Medicine 381 (22), 2091-2102, 2019
Breast implants and the risk of anaplastic large-cell lymphoma in the breast
M de Boer, FE van Leeuwen, M Hauptmann, LIH Overbeek, JP de Boer, ...
JAMA oncology 4 (3), 335-341, 2018
Breast implants and the risk of anaplastic large-cell lymphoma in the breast
M de Boer, FE van Leeuwen, M Hauptmann, LIH Overbeek, JP de Boer, ...
JAMA oncology 4 (3), 335-341, 2018
The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic …
MBI Lobbes, R Prevos, M Smidt, VCG Tjan-Heijnen, M Van Goethem, ...
Insights into imaging 4, 163-175, 2013
Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme
MBI Lobbes, U Lalji, J Houwers, EC Nijssen, PJ Nelemans, ...
European radiology 24, 1668-1676, 2014
Contrast enhanced mammography: techniques, current results, and potential indications
MBI Lobbes, ML Smidt, J Houwers, VC Tjan-Heijnen, JE Wildberger
Clinical radiology 68 (9), 935-944, 2013
Contrast-enhanced mammography: state of the art
MS Jochelson, MBI Lobbes
Radiology 299 (1), 36-48, 2021
Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria
UC Lalji, C Jeukens, I Houben, PJ Nelemans, RE van Engen, ...
European radiology 25, 2813-2820, 2015
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
S Saadatmand, HA Geuzinge, EJT Rutgers, RM Mann, ...
The Lancet Oncology 20 (8), 1136-1147, 2019
Contrast enhanced spectral mammography: a review
BK Patel, MBI Lobbes, J Lewin
Seminars in Ultrasound, CT and MRI 39 (1), 70-79, 2018
Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study
UC Lalji, IPL Houben, R Prevos, S Gommers, M van Goethem, ...
European radiology 26, 4371-4379, 2016
The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefit of additional breast MRI
MBI Lobbes, UC Lalji, PJ Nelemans, I Houben, ML Smidt, E Heuts, ...
Journal of Cancer 6 (2), 144, 2015
MR imaging as an additional screening modality for the detection of breast cancer in women aged 50–75 years with extremely dense breasts: the DENSE trial study design
MJ Emaus, MF Bakker, PHM Peeters, CE Loo, RM Mann, MDF De Jong, ...
Radiology 277 (2), 527-537, 2015
Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging
U Bick, RM Trimboli, A Athanasiou, C Balleyguier, PAT Baltzer, ...
Insights into Imaging 11, 1-18, 2020
A novel less-invasive approach for axillary staging after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer by combining radioactive iodine seed …
TJA van Nijnatten, JM Simons, ML Smidt, CC van der Pol, PJ van Diest, ...
Clinical breast cancer 17 (5), 399-402, 2017
The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review
VJL Kuijs, M Moossdorff, RJ Schipper, RGH Beets-Tan, EM Heuts, ...
Insights into imaging 6 (2), 203-215, 2015
Radiation exposure of contrast-enhanced spectral mammography compared with full-field digital mammography
CR Jeukens, UC Lalji, E Meijer, B Bakija, R Theunissen, JE Wildberger, ...
Investigative radiology 49 (10), 659-665, 2014
Is there more than C-reactive protein and fibrinogen?: The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary …
MBI Lobbes, E Lutgens, S Heeneman, K Cleutjens, ME Kooi, ...
Atherosclerosis 187 (1), 18-25, 2006
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre …
LM Van Roozendaal, MLG Vane, T Van Dalen, JA van der Hage, ...
BMC cancer 17 (1), 1-8, 2017
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
B Goorts, TJA van Nijnatten, L de Munck, M Moossdorff, EM Heuts, ...
Breast cancer research and treatment 163, 83-91, 2017
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20